论文部分内容阅读
卵巢癌确诊时多为晚期,术后化疗在70年代前为烷化剂单一化疗模式;采用铂类化合物后,多选用与烷化剂联合化疗。本文对德国莱化锡大学妇产医院1976年1月1日～1982年12月31日和1985年1月1日～1991年12月31日Ⅲ期卵巢上皮性癌治疗结果进行回顾性研究。 从80年代中期起,含铂类治疗为首选治疗,而在此前按惯例采用非铂类治疗。治疗开始后6个月借助临床和影像学结果评价治疗效果。患者平均年
Ovarian cancer is mostly diagnosed late, postoperative chemotherapy in the 70 years before the single alkylating chemotherapy model; the use of platinum compounds, the more choice and alkylating agent combined with chemotherapy. This article retrospectively studied the results of stage Ⅲ ovarian epithelial cancer treatment from January 1, 1976 to December 31, 1976, and January 1, 1985 to December 31, 1991 at the Hospital of Obstetrics and Gynecology, University of Leiktinburg, Germany. Since the mid-1980s, platinum-based therapy has been the preferred treatment, and non-platinum therapy has been used conventionally. Six months after the start of treatment, clinical and radiological findings were used to evaluate the efficacy of the treatment. Patient average years